637. Treatment Outcomes in Secondary Analysis Populations of Adult Patients the ALLIUM Phase 3 study Comparing Cefepime-Enmetazobactam to Piperacillin-Tazobactam for Complicated Urinary Tract Infections (cUTI) or Acute Pyelonephritis (AP)

BACKGROUND: Superior treatment outcomes were observed with the β-lactam/β-lactamase inhibitor combination of cefepime-enmetazobactam (FPE) compared to piperacillin-tazobactam (PTZ) in the primary efficacy population (m-MITT) of the ALLIUM phase 3 study of adult patients with cUTI/AP. We present here...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaye, Keith S, Belley, Adam, Barth, Philip, Lahlou, Omar, Velicitat, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643813/
http://dx.doi.org/10.1093/ofid/ofab466.834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643813/
http://dx.doi.org/10.1093/ofid/ofab466.834

Ejemplares similares